T. KALİNCİK Et Al. , "Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis," ECTRIMS 2014 , 2014
KALİNCİK, T. Et Al. 2014. Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis. ECTRIMS 2014 .
KALİNCİK, T., Horakova, D., SPELMAN, T., Jokubaitis, V. G., Trojano, M., Lugaresi, A., ... Izquierdo, G.(2014). Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis . ECTRIMS 2014
KALİNCİK, TOMAS Et Al. "Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis," ECTRIMS 2014, 2014
KALİNCİK, TOMAS Et Al. "Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis." ECTRIMS 2014 , 2014
KALİNCİK, T. Et Al. (2014) . "Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis." ECTRIMS 2014 .
@conferencepaper{conferencepaper, author={TOMAS KALİNCİK Et Al. }, title={Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis}, congress name={ECTRIMS 2014}, city={}, country={}, year={2014}}